Gujarat FDCA Grants Manufacturing Approval To Several Cos For Amphotericin B To Treat Black Fungus

The Gujarat Food and Drug Control Administration (FDCA) has granted approval to various pharmaceutical companies to manufacture amphotericin B injection, an antifungal medication used for serious fungal infections including mucormycosis and leishmaniasis.“The pharmaceutical companies which started production include Emcure Pharmaceuticals (Ahmedabad), Lyka Labs (Anleshwar), Gufic Biosciences (Navsari), Sun Pharmaceuticals (Halol), Alembic Pharmaceuticals (Karkhadi), Intas Pharmaceuticals (Matoda), BDR Pharmaceuticals (Vanseti), Rusan Pharma (Gandhidham), Sumar Biotech (Gojhariya), Swiss Parentals (Bavla), Punishka Healthcare (Pipan), Bharat Parentals (Vadodara),” stated Gujarat FDCA Commissioner Dr H G Koshia.Dr H G Koshia added, “We have issued as many as 19 licences since May 2021 to various companies to manufacture amphotericin B in the form of both liposomal and emulsion injections.”Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis. For certain infections, it is given with flucytosine. It is typically given by injection into a vein.Mucormycosis, also known as black fungus, is a serious fungal infection, usually in people with reduced ability to fight infections. Symptoms depend on where in the body the infection occurs. It most commonly infects the nose, sinuses, eye and brain resulting in a runny nose, one sided facial swelling and pain, headache, fever, blurred vision, swollen and bulging eye, and tissue death. Other forms of disease may infect the lungs, stomach and intestines, and skin.Gujarat is the largest manufacturer of API amphotericin in India.Earlier, Gujarat FDCA has given approval to seven more units to manufacture remdesivir injection. This includes units of Cadila Healthcare Limited and Lincoln Pharmaceuticals. Gujarat currently has 14 units which are manufacturing remdesivir. This will take total number of remdesivir manufacturing units to 21, stated Dr H G Koshia.The units under Cadila Healthcare Ltd include the facilities of Amneal Pharmaceuticals, German Remedies, Gufi Biosciences Ltd, Elsiyum Pharmaceuticals, Abaris Pharmaceuticals.Gujarat FDCA makes optimum use of information technology for achieving excellence in performance. FDCA, Gujarat is the first State to initiate online software for sales and manufacturing licenses.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!